The hepatic insulin resistance derived from NAFLD generally implies the insufficient ability of insulin to suppress glycogenolysis, gluconeogenesis, and glucose output in the liver, thereby causing decreases in glucose disposal, consequently leading to type 2 diabetes (T2DM), and metabolic syndrome [2, 3]. This evidence concerns the gene INS and Insulin resistance.